MA39715A - Formes polymorphes de l'acide 4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylique et de son sel de disodium, procédé de préparation desdites formes polymorphes et leur utilisation - Google Patents

Formes polymorphes de l'acide 4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylique et de son sel de disodium, procédé de préparation desdites formes polymorphes et leur utilisation

Info

Publication number
MA39715A
MA39715A MA039715A MA39715A MA39715A MA 39715 A MA39715 A MA 39715A MA 039715 A MA039715 A MA 039715A MA 39715 A MA39715 A MA 39715A MA 39715 A MA39715 A MA 39715A
Authority
MA
Morocco
Prior art keywords
pyrrolo
quinoline
dihydro
preparation
disodium salt
Prior art date
Application number
MA039715A
Other languages
English (en)
Inventor
Rajulu Gavara Govinda
Ravindra Chandrappa Koramangala
Tom Thomas Puthiaparampil
Ganesh Sambasivam
Original Assignee
Anthem Biosciences Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anthem Biosciences Private Ltd filed Critical Anthem Biosciences Private Ltd
Publication of MA39715A publication Critical patent/MA39715A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une forme polymorphe de pqq et/ou de ses sels, représentée par la formule (i), dans laquelle "n" et "m" sont choisis dans le groupe constitué par : (a) "n" = 3, "m" = 0 et (b) "n" = 1, "m" = 2; et r3 est na+. Un procédé de préparation de la forme polymorphe du composé de formule (i) et/ou de ses sels, une composition les contenant et leur utilisation sont en outre décrits.
MA039715A 2014-04-16 2015-04-14 Formes polymorphes de l'acide 4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylique et de son sel de disodium, procédé de préparation desdites formes polymorphes et leur utilisation MA39715A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1988CH2014 2014-04-16

Publications (1)

Publication Number Publication Date
MA39715A true MA39715A (fr) 2015-10-22

Family

ID=53059367

Family Applications (1)

Application Number Title Priority Date Filing Date
MA039715A MA39715A (fr) 2014-04-16 2015-04-14 Formes polymorphes de l'acide 4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylique et de son sel de disodium, procédé de préparation desdites formes polymorphes et leur utilisation

Country Status (6)

Country Link
US (1) US20170022200A1 (fr)
EP (1) EP3131899A1 (fr)
JP (1) JP2017513863A (fr)
CN (1) CN106255691A (fr)
MA (1) MA39715A (fr)
WO (1) WO2015159236A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10364244B2 (en) * 2015-09-25 2019-07-30 Zhejiang Hisun Pharmaceutical Co., Ltd. Crystal form of pyrroloquinoline quinone sodium salt and preparation method and use thereof
CN105315278B (zh) * 2015-11-02 2018-01-16 诸城市浩天药业有限公司 吡咯喹啉醌a晶型及其制备方法
CN105218543B (zh) * 2015-11-02 2017-05-10 诸城市浩天药业有限公司 吡咯喹啉醌b晶型及其制备方法
KR20210052433A (ko) * 2018-08-30 2021-05-10 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 광열화억제제, 그것을 포함하는 음료, 및 광열화억제방법
JP7301347B2 (ja) * 2019-05-22 2023-07-03 株式会社ブルーム・クラシック サーチュイン１活性化剤及びサーチュイン１活性化用皮膚化粧料
CN112125899B (zh) * 2019-06-24 2023-01-03 浙江可明生物医药有限公司 吡咯并喹啉醌二钠盐结晶、其制备方法及包含其的组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3475969B2 (ja) 1993-08-27 2003-12-10 大日本インキ化学工業株式会社 共重合体樹脂エマルジョン、その製造方法及び防湿加工用組成物
US20070072894A1 (en) 2005-03-24 2007-03-29 Kempf J V Synthesis of pyrroloquinoline quinone (PQQ)
CN101193888A (zh) * 2005-03-24 2008-06-04 Clf医疗技术加速程序有限公司 吡咯喹啉醌（pqq）的合成方法
CN101885725A (zh) * 2009-05-12 2010-11-17 江苏道琪生物科技有限公司 吡咯喹啉醌钠盐衍生物及其制备方法
US9163014B2 (en) 2009-07-16 2015-10-20 Mitsubishi Gas Chemical Company, Inc. Crystals of pyrroloquinolinequinone sodium salts
JPWO2011055796A1 (ja) * 2009-11-06 2013-03-28 三菱瓦斯化学株式会社 ピロロキノリンキノンのフリー体
JP5979376B2 (ja) * 2010-11-26 2016-08-24 三菱瓦斯化学株式会社 溶解性の高いピロロキノリンキノン塩及びその製造方法
DK2722331T3 (da) * 2011-06-16 2017-11-20 Mitsubishi Gas Chemical Co Pyrroloquinolinquinondinatriumsaltkrystal og fremgangsmåde til fremstilling af samme
JP2013112677A (ja) * 2011-12-01 2013-06-10 Mitsubishi Gas Chemical Co Inc ピロロキノリンキノンジナトリウム結晶
JP5962254B2 (ja) * 2012-06-27 2016-08-03 三菱瓦斯化学株式会社 高品質ピロロキノリンキノンの製造方法

Also Published As

Publication number Publication date
US20170022200A1 (en) 2017-01-26
WO2015159236A1 (fr) 2015-10-22
JP2017513863A (ja) 2017-06-01
CN106255691A (zh) 2016-12-21
EP3131899A1 (fr) 2017-02-22

Similar Documents

Publication Publication Date Title
MA39715A (fr) Formes polymorphes de l'acide 4,5-dihydro-1h-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylique et de son sel de disodium, procédé de préparation desdites formes polymorphes et leur utilisation
IN2014MN02106A (fr)
PH12018501644A1 (en) Tlr7 agonist maleate salt, crystalline forms c, d and e thereof, preparation methods and uses of maleate salt and crystalline forms
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
PH12016500169A1 (en) Polymorph of syk inhibitors
WO2016077464A8 (fr) Dérivés d'acides aminés et leurs utilisations
CA2826751C (fr) Procedes de synthese de quinoleines et compositions pharmaceutiques les incluant
MX2017015496A (es) Fosforilacion selectiva sin disolvente.
SG10201806565SA (en) Heterocyclic carboxylic acids as activators of soluble guanylate cyclase
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
MX2015011723A (es) Proceso para la preparacion de una sal de sodio de (2s, 5r) -2-carboxamido-7-oxo-6-sulfooxi-1,6-diaza-biciclo[3.2.1]-octano.
SG11201811835YA (en) Diorganylphosphinic acid salts, method for the production thereof and the use thereof
TN2019000204A1 (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
AU2018253590A1 (en) Imidazopyridazine compounds
PH12015502802A1 (en) Formulation comprising a hypolipidemic agent
MA43066A (fr) Procédés de préparation d'acides biliaires et de leurs dérivés
MX2016001096A (es) Sales de dasatinib en forma amorfa.
WO2013177534A3 (fr) Nouveaux dérivés d'acide salicylique, sel de qualité pharmaceutique correspondant, composition et procédé d'utilisation correspondants
MX2018009503A (es) Sal de trifluoroacetato de agonista de tlr7 y forma cristalina b de la misma, metodos de preparacion y usos.
MX2016005993A (es) Anfifilos biscationicos y triscationicos como agentes antimicrobianos.
MX2016004963A (es) Sal y formas cristalinas de inhibidores de quinasa tipo polo-4.
MY185971A (en) Pyranodipyridine compound
PH12019500822A1 (en) Crystalline forms of eravacycline
MX2013008164A (es) Proceso para hacer inhibidores de girasa y topoisomerasa iv.
CA2922375C (fr) Formes de sels d'alpha-tea: compositions et utilisations therapeutiques